Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension
Christopher J. Rhodes(Centre for Human Genetics), Martin R. Wilkins(Hammersmith Hospital), Stefan Gräf(University of Cambridge), Gerry Coghlan(Papworth Hospital NHS Foundation Trust), David G. Kiely(Royal Hallamshire Hospital), Matthias Haimel(University of Cambridge), Stephen J. Wort(Royal Brompton Hospital), Kévin Rue-Albrecht(Hammersmith Hospital), J. Simon R. Gibbs(National Institutes of Health), Nicholas W. Morrell(University of Cambridge), Mark Toshner, Marta Bleda(University of Cambridge), Paul A. Corris(Newcastle College), Charaka Hadinnapola(University of Cambridge), G.K. Watson(Hammersmith Hospital), John Wharton(Pfizer (United Kingdom)), Pavandeep Ghataorhe(GlaxoSmithKline (United Kingdom)), Allan Lawrie(University of Sheffield), Luke Howard(Imperial College Healthcare NHS Trust), Andrew J. Peacock(Pulmonary Vascular Research Institute), Joanna Pepke‐Żaba(Papworth Hospital NHS Foundation Trust)
Cited by 214
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k